Home
Biogen BIIB spent $1.1M on lobbying in Q2 2026 · Health Issues, Medicare and 3 more issues
Trade details
- Type
- Lobbying report
- Amount
- $1,060,000
- Quarter
- Q2 2026
- Stock
- Biogen BIIB
- Client
- Biogen
- Reported
- 26/07/20
Down 27.4% from last quarter
What else happened in Biogen around then
Filed or reported within 30 days of the trade day · 05/31~07/30Biogen's other lobbying reports
- Biogen
LobbyingBiogen
LobbyingBiogen
BIIB
$50K
$50K
Reported 07/20
for Q2
- Biogen
LobbyingBiogen
LobbyingBiogen
BIIB
$50K
$50K
Reported 07/20
for Q2
- Biogen
LobbyingBiogen
LobbyingBiogen
BIIB
$60K
$60K
Reported 07/20
for Q2
- Biogen
LobbyingBiogen
LobbyingBiogen
BIIB
$50K
$50K
Reported 04/20
for Q1
- Biogen
LobbyingBiogen
LobbyingBiogen
BIIB
$1.5M
$1.5M
Reported 04/20
for Q1